ID20165A - Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis - Google Patents

Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis

Info

Publication number
ID20165A
ID20165A IDW980073D ID980073D ID20165A ID 20165 A ID20165 A ID 20165A ID W980073 D IDW980073 D ID W980073D ID 980073 D ID980073 D ID 980073D ID 20165 A ID20165 A ID 20165A
Authority
ID
Indonesia
Prior art keywords
dimetoxicinamoil
aminobenzoat
restenosis
prevention
acid
Prior art date
Application number
IDW980073D
Other languages
English (en)
Inventor
Juichi Fukuyama
Keiji Miyazawa
Shuichiro Hamano
Arao Ujiie
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25101171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID20165(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of ID20165A publication Critical patent/ID20165A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW980073D 1996-12-30 1997-12-19 Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis ID20165A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/774,418 US6019104A (en) 1996-12-30 1996-12-30 Method for the treatment or prevention of restenosis associated with coronary intervention

Publications (1)

Publication Number Publication Date
ID20165A true ID20165A (id) 1998-10-15

Family

ID=25101171

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW980073D ID20165A (id) 1996-12-30 1997-12-19 Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis

Country Status (19)

Country Link
US (1) US6019104A (id)
EP (1) EP0891185A2 (id)
KR (1) KR19990087396A (id)
CN (1) CN1220599A (id)
AR (1) AR009446A1 (id)
AU (1) AU7854198A (id)
BR (1) BR9707877A (id)
CA (1) CA2247306A1 (id)
CZ (1) CZ251198A3 (id)
EA (1) EA001931B1 (id)
HU (1) HUP9904029A3 (id)
ID (1) ID20165A (id)
IL (1) IL125660A0 (id)
NO (1) NO983947D0 (id)
NZ (1) NZ331338A (id)
PE (1) PE27399A1 (id)
TR (1) TR199801698T1 (id)
WO (1) WO1998029104A2 (id)
ZA (1) ZA9711719B (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999056663A2 (en) * 1998-05-05 1999-11-11 Scimed Life Systems, Inc. Stent with smooth ends
BR0007901A (pt) * 1999-02-03 2001-10-30 Smithkline Beecham Corp Método para a preservação ou redução deeventos cardiovasculares associados comintervenção coronária
TR200102245T2 (tr) * 1999-02-03 2002-05-21 Smithkline Beecham Corporation Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
AU2001243248A1 (en) * 2000-02-23 2001-09-03 Smith Kline Beecham Corporation Method for the prevention or reduction of vascular access dysfunction
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640710B2 (id) * 1973-01-18 1981-09-22
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
US4337270A (en) * 1980-05-21 1982-06-29 Hisamitsu Pharmaceutical Co., Inc. Novel anthranilic acid derivatives
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤

Also Published As

Publication number Publication date
NZ331338A (en) 2000-12-22
WO1998029104A3 (en) 1998-10-01
HUP9904029A2 (hu) 2000-05-28
EA001931B1 (ru) 2001-10-22
WO1998029104A2 (en) 1998-07-09
AR009446A1 (es) 2000-04-12
EA199800781A1 (ru) 1999-12-29
NO983947D0 (no) 1998-08-27
CA2247306A1 (en) 1998-07-09
KR19990087396A (ko) 1999-12-27
CN1220599A (zh) 1999-06-23
IL125660A0 (en) 1999-04-11
BR9707877A (pt) 1999-07-27
HUP9904029A3 (en) 2000-11-28
EP0891185A2 (en) 1999-01-20
TR199801698T1 (xx) 1999-03-22
ZA9711719B (en) 1998-06-25
PE27399A1 (es) 1999-03-31
US6019104A (en) 2000-02-01
AU7854198A (en) 1998-07-31
CZ251198A3 (cs) 1999-08-11

Similar Documents

Publication Publication Date Title
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
FI20000720L (fi) Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
FI962557A0 (fi) PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
DE69310065D1 (de) Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose
NO20011409L (no) Farmasöytiske midler for behandling av Parkinsonssykdom, ADHD og mikroadenomer
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
IS5366A (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO982562D0 (no) Sammensetning for behandling av smerte
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
IL125660A0 (en) Pharmaceutical composition comprising 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the aminobenzoic acid for the treatment or prevention of restenosis and its manufacture
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose
RU97111440A (ru) Препарат для лечения отморожений
DK8893D0 (da) Medicament for treatment or prevention of disease